Indication: 1. Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. 2. Isoniazid alone is suitable for the prevention of various types of tuberculosis: 1. Family members or close contacts of patients recently diagnosed with tuberculosis; 2. Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; 3. Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose tuberculin purified protein derivative test is positive; 4. Patients under 35 years old with a positive tuberculin purified protein derivative test; 5. People who are known or suspected to be infected with HIV, whose tuberculin purified protein derivative test is positive, or who have close contact with patients with active pulmonary tuberculosis.

Indication: This product is suitable for the treatment of pulmonary tuberculosis and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis in combination with other anti-tuberculosis drugs, and can also be used to treat atypical Mycobacterium tuberculosis infection.

Indication: This product is suitable for the treatment of pulmonary tuberculosis and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis in combination with other anti-tuberculosis drugs, and can also be used to treat atypical Mycobacterium tuberculosis infection.

Indication: This product is suitable for the treatment of pulmonary tuberculosis and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis in combination with other anti-tuberculosis drugs, and can also be used to treat atypical Mycobacterium tuberculosis infection.

Indication: This product is suitable for the treatment of pulmonary tuberculosis and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis in combination with other anti-tuberculosis drugs, and can also be used to treat atypical Mycobacterium tuberculosis infection.

Indication: This product is suitable for the treatment of pulmonary tuberculosis and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis in combination with other anti-tuberculosis drugs, and can also be used to treat atypical Mycobacterium tuberculosis infection.

Indication: It is used in combination with other anti-tuberculosis drugs to treat various types of pulmonary tuberculosis, endobronchial tuberculosis and extrapulmonary tuberculosis. It can also be used as a protective drug for tuberculosis-related surgeries, and can also be used to prevent tuberculosis infection and recurrence during long-term or high-dose corticosteroid and immunosuppressive therapy.

Indication: It is used for non-productive dry cough caused by colds, as well as cough caused by upper respiratory tract infections, acute bronchitis and whooping cough, tuberculous pleurisy, chronic bronchitis combined with emphysema, cor pulmonale, etc.

Indication: This product is only effective against mycobacteria and is used in combination with other anti-tuberculosis drugs (such as streptomycin, isoniazid, rifampicin and ethambutol) to treat tuberculosis.